학술논문

A phase I study of temsirolimus as novel therapeutic drug for patients with unresectable hepatocellular carcinoma (HCC).
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; MAY 20 2013, 31 15, 2p. Supplement: S
Subject
Language
English
ISSN
15277755